Related Experiment Video
Updated: Aug 8, 2026

04:11
Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
[Hepatitis B and C infection in late repatriates]
M Holbach1, G G Frösner, B Holbach
1Abteilung Arbeitsmedizin des Bezirks Unterfranken, Lohr.
MMW Fortschritte Der Medizin
|June 3, 2006
Summary
Late repatriates returning to Germany show higher prevalence of viral hepatitis B and C. Many were unaware of their infection, highlighting the need for targeted screening programs.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Context:
- Late repatriates returning to Germany from high-prevalence regions (Russia, Ukraine, Kazakhstan) represent a unique demographic.
- Previous studies have not extensively evaluated viral hepatitis prevalence in this specific population group.
- Understanding infection rates is crucial for public health interventions.
Purpose:
- To determine the prevalence of past or present viral hepatitis B and C infections among late repatriates.
- To identify individuals who are potential sources of infection (PCR positive).
- To compare prevalence rates with the general German population.
Summary:
- Among 105 late repatriates tested, 20% had evidence of hepatitis B (Anti-HBc) and 3% had evidence of hepatitis C (Anti-HCV).
- 5% of individuals tested positive for HBV-DNA or HCV-DNA via PCR, indicating active infection, and were unaware of their status.
- The prevalence of both hepatitis B and C was significantly higher than in the general German population.
Impact:
- Highlights a higher-than-expected burden of viral hepatitis B and C in late repatriates.
- Suggests that current screening strategies may not adequately reach this population.
- Recommends targeted screening for viral hepatitis B and C for all late repatriates from high-prevalence areas.
Related Concept Videos
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
